We are live on
!
Find out more
Manulife (Manufacturers Life Insurance) Portfolio holdings
AUM
$116B
1-Year Est. Return
26.37%
This Fund
S&P 500
This Quarter
Est. Return
+11.31%
1 Year Est. Return
+26.37%
3 Year Est. Return
+67.38%
5 Year Est. Return
+85.79%
10 Year Est. Return
+313.78%
AUM
$112B
AUM Growth
+$6.13B
(+5.8%)
Cap. Flow
-$3B
Cap. Flow
% of AUM
-2.68%
Top 10 Holdings %
Top 10 Hldgs %
21.04%
Holding
3,037
New
148
Increased
1,035
Reduced
1,659
Closed
133
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$493M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$353M |
| 3 |
Canadian Imperial Bank of Commerce
CM
|
+$268M |
| 4 |
Elevance Health
ELV
|
+$196M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$370M |
| 2 |
Amazon
AMZN
|
+$330M |
| 3 |
Morgan Stanley
MS
|
+$284M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$277M |
| 5 |
Microsoft
MSFT
|
+$276M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.62% |
| 2 | Financials | 15.58% |
| 3 | Healthcare | 11.91% |
| 4 | Consumer Discretionary | 9.88% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2576
LSI Industries
LYTS
$906M
| $174K | ﹤0.01% |
10,242
-78
| -0.8% | -$1.25K |
|
2577
Theravance Biopharma
TBPH
$878M
| $174K | ﹤0.01% |
15,747
+1,020
| +7% | +$9.92K |
|
|
NFBK
2578
DELISTED
Northfield Bancorp
NFBK
| $174K | ﹤0.01% |
15,129
+1,164
| +8% | +$12.9K |
|
2579
Corsair Gaming
CRSR
$1.47B
| $172K | ﹤0.01% |
18,249
+239
| +1% | +$1.93K |
|
2580
The Honest Company
HNST
$545M
| $172K | ﹤0.01% |
33,734
+4,378
| +15% | +$21K |
|
2581
Stoke Therapeutics
STOK
$2.09B
| $171K | ﹤0.01% |
15,099
+1,862
| +14% | +$17.7K |
|
2582
EVgo
EVGO
$516M
| $171K | ﹤0.01% |
46,791
+7,331
| +19% | +$25.1K |
|
2583
NerdWallet
NRDS
$632M
| $170K | ﹤0.01% |
15,489
+2,877
| +23% | +$28.9K |
|
2584
Thryv Holdings
THRY
$93.3M
| $169K | ﹤0.01% |
13,887
+1,023
| +8% | +$13.2K |
|
|
CRGX
2585
DELISTED
CARGO Therapeutics
CRGX
| $168K | ﹤0.01% |
40,849
+57
| +0.1% | +$244 |
|
2586
Lindblad Expeditions
LIND
$2.25B
| $168K | ﹤0.01% |
14,406
+1,222
| +9% | +$12.1K |
|
2587
Woodside Energy
WDS
$43.3B
| $168K | ﹤0.01% |
10,868
-14,147
| -57% | -$198K |
|
2588
The RealReal
REAL
$1.35B
| $168K | ﹤0.01% |
34,982
-72
| -0.2% | -$396 |
|
2589
Monro
MNRO
$365M
| $167K | ﹤0.01% |
11,215
+444
| +4% | +$6.4K |
|
2590
Amylyx Pharmaceuticals
AMLX
$2.54B
| $167K | ﹤0.01% |
+25,999
| New | +$126K |
|
2591
Real Brokerage
REAX
$501M
| $166K | ﹤0.01% |
36,917
+3,173
| +9% | +$13.7K |
|
2592
Wabash National
WNC
$521M
| $166K | ﹤0.01% |
15,660
+109
| +0.7% | +$1.05K |
|
2593
Keros Therapeutics
KROS
$217M
| $166K | ﹤0.01% |
12,451
+988
| +9% | +$13.3K |
|
2594
Columbus McKinnon
CMCO
$544M
| $166K | ﹤0.01% |
10,885
+852
| +8% | +$13K |
|
2595
Orthofix Medical
OFIX
$417M
| $166K | ﹤0.01% |
14,867
+2,589
| +21% | +$32.1K |
|
|
KALV
2596
DELISTED
KalVista Pharmaceuticals
KALV
| $165K | ﹤0.01% |
14,626
+818
| +6% | +$10K |
|
|
ATYR
2597
aTyr Pharma
ATYR
$56.1M
| $165K | ﹤0.01% |
+32,477
| New | +$128K |
|
2598
LSB Industries
LXU
$706M
| $165K | ﹤0.01% |
21,098
+1,015
| +5% | +$6.95K |
|
2599
Arhaus
ARHS
$1.39B
| $164K | ﹤0.01% |
18,973
+717
| +4% | +$5.99K |
|
2600
Community Health Systems
CYH
$420M
| $164K | ﹤0.01% |
48,312
+3,058
| +7% | +$9.84K |
|
Similar funds
VAM
Manulife (Manufacturers Life Insurance)'s Q2 2025 Portfolio in Review
As of Q2 2025, Manulife (Manufacturers Life Insurance) held 3,037 positions worth $112B, up 5.8% from $106B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Manulife (Manufacturers Life Insurance)'s Q2 2025 filing shows 148 new, 1,035 increased, 1,659 reduced and 133 closed positions. Its largest new stake was iShares Russell 2000 Growth ETF: 217,719 shares worth $62.2M. The largest sale was Apple, an estimated $370M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- Manulife (Manufacturers Life Insurance)'s largest Q2 2025 buy was iShares Russell 2000 Growth ETF: 217,719 shares worth $62.2M.
- Manulife (Manufacturers Life Insurance) added most to Hologic in Q2 2025, an estimated $493M increase.
- Manulife (Manufacturers Life Insurance)'s biggest Q2 2025 reduction was Apple, cutting an estimated $370M.
- Manulife (Manufacturers Life Insurance) fully exited iShares MSCI India ETF in Q2 2025, selling an estimated $128M.
- Manulife (Manufacturers Life Insurance)'s ten largest holdings make up 21% of its $112B portfolio in Q2 2025.
- Manulife (Manufacturers Life Insurance) opened 148 new positions and closed 133 in Q2 2025.
- Manulife (Manufacturers Life Insurance)'s portfolio value rose 5.8% quarter-over-quarter to $112B.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2025, filed 14 Aug 2025.